Who is Cardionomous?

It’s not very often you see multiple recently published applications assigned to a company that doesn’t have a functional website, so when you do, it makes you wonder. This is the case with Cardionomous, who recently had four applications published for an AI-based system which provides a heart health indicator based on a single-lead heartbeat waveform for a user.

Cardionomous does have a registered trademark and available mobile app, which is published by the company ITMS. ITMS is a Chile-based firm that incorporates AI into technology for doctors and patients to reduce diagnosis & treatment time and improve cost-effectiveness.

What’s next for Cardionomous? 

Also, given the lack of information available, the irony of a company name that plays on “anonymous” is not lost on us.

Related Posts

Cala Health Claims to Have the only Patented Neurostimulation for Essential Tremor Treatment. The Patent Data Disagrees

Cala Health has figured out that innovations backed by patents make them exponentially more valuable in the marketplace. However, in a zest…


Capital One is Investing in AI Biotech? What’s in their wallet?

In the past 18 months, Capital One has expanded past its usual banking activities, and begun exploring the AI Biotech Sector. But do they…


Google AI Reinvents Speech Recognition. Who will follow?

There is no doubt that the big 5 tech companies (Apple, Amazon, Google, Facebook, and Microsoft) have developed massive IP portfolios in…